Getinge B, SE0000202624

Getinge stock holds steady as Tradegate opens higher

Published on 09/01/2026 at 12:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Getinge stock trades higher on Tradegate at EUR 22.14 on September 1, 2026, with year-to-date performance up 8.26%.

Börsenhandelsraum Nasdaq Stockholm mit Healthcare-Aktienchart-Bildschirmen und Händlern
Getinge AB (ISIN SE0000202624) wird redaktionell mit dem Handelsraum der Börse Nasdaq Stockholm kombiniert, Illustration mit AI erstellt.

Getinge AB stock (SE0000202624) traded at EUR 22.14 on Tradegate at 09:30:30 on September 1, 2026, after a 1.10 percent gain in the latest quote shown in the market snapshot. The same snapshot also shows the shares up 8.26 percent since January 1, giving investors a fresh reference point for the session.

Tradegate sets the tone

The quote page for Getinge shows a 5-day move of minus 1.08 percent and a year-to-date gain of 8.26 percent, which frames the stock as firmer over the year despite short-term softness. That combination matters because it puts the current move beside a visible 2026 trend rather than a single print.

Getinge's investor page is the official corporate home for reports, presentations, and releases, and it remains the right place to track the next published quarter from the company itself. For now, the market snapshot and the company's latest published reporting cycle are the main reference points for the shares.

What the numbers say

The latest supported market figures in this call are the EUR 22.14 quote, the plus 1.10 percent intraday move, the minus 1.08 percent 5-day change, and the plus 8.26 percent year-to-date performance, all visible on September 1, 2026. That mix gives a cleaner read than a headline move alone.

For investors, the key question is whether the stock can build on that 8.26 percent year-to-date gain while the next company update stays the main fundamental check. The current snapshot suggests the share price is still close enough to the recent tape to matter, but not detached from it.

Getinge's product base

Getinge is a medical-technology group whose portfolio spans hospital workflows, intensive-care equipment, and surgical systems. That product mix is why its shares often react not just to pricing and margins, but also to procedure volumes and hospital spending trends.

Getinge shares in view

As of September 1, 2026, Getinge shares were quoted at EUR 22.14 on Tradegate. The year's gain of 8.26 percent leaves the stock with a measurable buffer above the level it showed at the start of 2026.

Fact box

Company: Getinge AB
ISIN: SE0000202624
Ticker: GTN
Exchange: Tradegate
Price (as of September 1, 2026, 09:30:30 a.m. ET): EUR 22.14
Market cap: EUR 6.0 billion
Sector / Industry: Health Care / Medical Devices
Index membership: OMXS30

More on Getinge stock

Getinge investor relations

Disclaimer...

en | SE0000202624 | GETINGE B | boerse | 70035492 | bgmi